• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

射频消融与肝切除术治疗米兰标准内肝细胞癌的比较研究。

Radiofrequency ablation versus hepatic resection for hepatocellular carcinoma within the Milan criteria--a comparative study.

机构信息

Department of Surgery, Pamela Youde Nethersole Eastern Hospital, 3 Lok Man Road, Chai Wan, Hong Kong SAR, China.

出版信息

Int J Surg. 2013;11(1):77-80. doi: 10.1016/j.ijsu.2012.11.019. Epub 2012 Dec 6.

DOI:10.1016/j.ijsu.2012.11.019
PMID:23220487
Abstract

BACKGROUND

To compare the results of radiofrequency ablation (RFA) with hepatic resection in the treatment of hepatocellular carcinoma (HCC) within the Milan criteria.

METHODS

A nonrandomized comparative study was performed with 111 consecutive patients who underwent laparoscopic RFA (n = 31) or curative hepatic resection (n = 80) for HCC within Milan criteria.

RESULTS

Procedure related complications were less often and severe after RFA than resection (3.2% vs. 25%). There was no significant difference in hospital mortality (0% vs. 3.8%). Hospital stay was significantly shorter in the RFA group than in the resection group (mean, 3.8 vs. 6.8 days). The 1-, 3-, and 5-year disease-free survival rates for the RFA group and the resection group were 76%, 40%, 40% and 76%, 60%, 60%, respectively. Disease-free survival was significantly lower in the RFA group than in the resection group. The corresponding 1-, 3-, and 5-year overall survival rates for the RFA group and the resection group were 100%, 92%, 84%, and 92%, 75%, 71%, respectively. The overall survival for RFA and resection were not significantly different.

CONCLUSIONS

Our result showed comparable overall survival between RFA and surgery, although RFA was associated with a significantly higher tumor recurrence rate. RFA had the advantages over surgical resection in being less invasive and having lower morbidity.

摘要

背景

比较射频消融(RFA)与肝切除术治疗米兰标准内肝细胞癌(HCC)的结果。

方法

对 111 例连续接受腹腔镜 RFA(n = 31)或根治性肝切除术(n = 80)治疗米兰标准内 HCC 的患者进行非随机对照研究。

结果

RFA 后与切除术相关的并发症发生率较低且严重程度较轻(3.2% vs. 25%)。住院死亡率无显著差异(0% vs. 3.8%)。RFA 组的住院时间明显短于切除术组(平均 3.8 天 vs. 6.8 天)。RFA 组和切除术组的 1 年、3 年和 5 年无疾病生存率分别为 76%、40%、40%和 76%、60%、60%。RFA 组无疾病生存率明显低于切除术组。RFA 组和切除术组的 1 年、3 年和 5 年总生存率分别为 100%、92%、84%和 92%、75%、71%。RFA 和手术的总生存率无显著差异。

结论

我们的结果表明,RFA 与手术的总生存率相当,尽管 RFA 与更高的肿瘤复发率相关。RFA 具有创伤小、发病率低的优点,优于手术切除。

相似文献

1
Radiofrequency ablation versus hepatic resection for hepatocellular carcinoma within the Milan criteria--a comparative study.射频消融与肝切除术治疗米兰标准内肝细胞癌的比较研究。
Int J Surg. 2013;11(1):77-80. doi: 10.1016/j.ijsu.2012.11.019. Epub 2012 Dec 6.
2
Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.米兰标准内小肝细胞癌的手术切除与射频消融治疗对比
J Hepatobiliary Pancreat Surg. 2009;16(3):359-66. doi: 10.1007/s00534-009-0069-7. Epub 2009 Mar 20.
3
Experience with more than 500 minimally invasive hepatic procedures.拥有超过500例微创肝脏手术的经验。
Ann Surg. 2008 Sep;248(3):475-86. doi: 10.1097/SLA.0b013e318185e647.
4
Liver resection and radiofrequency ablation of very early hepatocellular carcinoma cases (single nodule <2 cm): a single-center study.肝切除术和射频消融治疗极早期肝细胞癌病例(单个结节<2cm):单中心研究。
Eur J Gastroenterol Hepatol. 2014 Mar;26(3):339-44. doi: 10.1097/MEG.0000000000000012.
5
Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study.HBV 相关小肝细胞癌射频消融或肝切除术后乙型肝炎病毒再激活:一项回顾性研究。
Eur J Surg Oncol. 2013 Aug;39(8):865-72. doi: 10.1016/j.ejso.2013.03.020. Epub 2013 Apr 15.
6
A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma.射频消融与手术切除治疗小肝癌的随机对照研究。
J Hepatol. 2012 Oct;57(4):794-802. doi: 10.1016/j.jhep.2012.05.007. Epub 2012 May 23.
7
A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria.一项比较符合米兰标准的 HCC 的射频消融与手术切除的随机临床试验。
Ann Surg. 2010 Dec;252(6):903-12. doi: 10.1097/SLA.0b013e3181efc656.
8
[The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma].[射频消融与手术切除治疗肝细胞癌的对比结果]
Korean J Hepatol. 2005 Mar;11(1):59-71.
9
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma.肝切除术与经皮射频消融治疗早期肝细胞癌的成本效益比较。
J Hepatol. 2013 Aug;59(2):300-7. doi: 10.1016/j.jhep.2013.04.009. Epub 2013 Apr 18.
10
Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?复发性肝细胞癌的治疗策略:挽救性移植、再次切除还是射频消融?
Liver Transpl. 2013 Apr;19(4):411-9. doi: 10.1002/lt.23605. Epub 2013 Mar 17.

引用本文的文献

1
Efficacy and safety of D-TACE followed by D-RFA for unresectable large hepatocellular carcinoma.经动脉化疗栓塞术(D-TACE)联合射频消融术(D-RFA)治疗不可切除性大肝细胞癌的疗效与安全性
Front Oncol. 2025 Jul 28;15:1530951. doi: 10.3389/fonc.2025.1530951. eCollection 2025.
2
Prognostic analysis of patients with CRLM based on CRS score: a single-center retrospective study.基于CRS评分的结直肠癌肝转移患者的预后分析:一项单中心回顾性研究。
BMC Cancer. 2025 Apr 17;25(1):718. doi: 10.1186/s12885-025-14135-7.
3
Radiofrequency ablation: mechanisms and clinical applications.
射频消融:机制与临床应用
MedComm (2020). 2024 Oct 2;5(10):e746. doi: 10.1002/mco2.746. eCollection 2024 Oct.
4
Efficacy and safety of B-ultrasound-guided radiofrequency ablation in the treatment of primary liver cancer: Systematic review and meta-analysis.B超引导下射频消融治疗原发性肝癌的疗效与安全性:系统评价与Meta分析
World J Gastrointest Surg. 2024 Sep 27;16(9):2986-2995. doi: 10.4240/wjgs.v16.i9.2986.
5
Comparison of liver resection and radiofrequency ablation in long-term survival among patients with early-stage hepatocellular carcinoma: a meta-analysis of randomized trials and high-quality propensity score-matched studies.比较肝切除术和射频消融术在早期肝细胞癌患者长期生存中的疗效:随机试验和高质量倾向评分匹配研究的荟萃分析。
World J Surg Oncol. 2024 Feb 19;22(1):56. doi: 10.1186/s12957-024-03330-8.
6
Combination transarterial chemoembolization and microwave ablation vs. microwave ablation monotherapy for hepatocellular carcinomas greater than 3 cm: a comparative study.联合经动脉化疗栓塞和微波消融与微波消融单药治疗大于 3cm 的肝细胞癌的比较研究。
Diagn Interv Radiol. 2023 Nov 7;29(6):805-812. doi: 10.4274/dir.2023.232159. Epub 2023 Sep 4.
7
Comparable and Complimentary Modalities for Treatment of Small-Sized HCC: Surgical Resection, Radiofrequency Ablation, and Microwave Ablation.治疗小尺寸肝癌的可比较及互补性方式:手术切除、射频消融和微波消融
J Clin Med. 2023 Jul 29;12(15):5006. doi: 10.3390/jcm12155006.
8
Radiofrequency ablation versus laparoscopic hepatectomy for treatment of hepatocellular carcinoma: a systematic review and meta-analysis.射频消融术与腹腔镜肝切除术治疗肝细胞癌的系统评价和荟萃分析
World J Surg Oncol. 2020 Aug 12;18(1):199. doi: 10.1186/s12957-020-01966-w.
9
Endoscopic hepatic resection and endoscopic radiofrequency ablation as initial treatments for hepatocellular carcinoma within the Milan criteria.内镜下肝切除术和内镜下射频消融术作为米兰标准内肝细胞癌的初始治疗方法。
Surg Today. 2020 Apr;50(4):402-412. doi: 10.1007/s00595-019-01903-9. Epub 2019 Nov 3.
10
Treatment Lines in Hepatocellular Carcinoma.肝细胞癌的治疗线
Visc Med. 2019 Aug;35(4):266-272. doi: 10.1159/000501749. Epub 2019 Jul 25.